Acute Central Serous Chorioretinopathy Outbreak during the COVID-19 Pandemic: A Pilot Study

被引:0
作者
Yahalomi, Tal [1 ]
Pikkel, Yael Sara [2 ,3 ]
Arnon, Roee [1 ]
Kinori, Michael [1 ]
Wood, Keren [1 ]
Pikkel, Joseph [1 ]
机构
[1] Ben Gurion Univ Negev, Samson Assuta Ashdod Hosp, Fac Hlth Sci, Dept Ophthalmol, IL-8410501 Beer Sheva, Israel
[2] Technion Israel Inst Technol, Rambam Hlth Care Campus, IL-3109601 Haifa, Israel
[3] Technion Israel Inst Technol, Fac Med, IL-3109601 Haifa, Israel
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 01期
关键词
central serous chorioretinopathy; CSCR; COVID-19; coronavirus; PHOTODYNAMIC THERAPY; MINERALOCORTICOID RECEPTOR; INTRAVITREAL BEVACIZUMAB; CORTISOL; FLUENCE; STRESS;
D O I
10.3390/medicina60010122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: This study aims to investigate the potential association between the COVID-19 pandemic and a new presentation of central serous chorioretinopathy (CSCR). Materials and Methods: A retrospective analysis was conducted, comparing the incidence of new-onset CSCR cases among ophthalmology patients in a regional medical facility in southern Israel between two distinct periods: the COVID-19 pandemic era in Israel, which occurred from 27 February 2020 to 20 December 2020, and the non-pandemic period from calendar years 2018 to 2021, excluding the specific epidemic phase mentioned. Disease severity was evaluated based on recovery time, visual acuity loss, and central macular thickness via OCT. Results: Over the four-year period, 35 new cases of CSCR were recorded. During the COVID-19 pandemic, 17 new cases (0.005% per population) were identified, compared with 18 new cases (0.002% per population) in the preceding three years. The odds ratio for acute CSCR during the pandemic was 2.83 (95% CI, 1.46-5.50) with a p-value of 0.02. CSCR cases during the pandemic seemed to exhibit worse clinical characteristics, though not statistically significant. Additionally, 22.2% of the COVID-19 pandemic group had confirmed COVID-19 cases, which was statistically significantly higher than the general population's reported cases (6%). Conclusion: The study revealed a statistically significant increase of over 2.5 times in acute CSCR incidence during the COVID-19 pandemic compared with non-pandemic periods. The findings suggest that the pandemic's stressful changes may have unintended consequences on the occurrence of CSCR, highlighting the importance of mental health support and psychoeducation for affected patients.
引用
收藏
页数:11
相关论文
共 47 条
  • [1] Advances in the treatment of central serous chorioretinopathy
    Abouammoh, Marwan A.
    [J]. SAUDI JOURNAL OF OPHTHALMOLOGY, 2015, 29 (04) : 278 - 286
  • [2] The role of the COVID-19 pandemic in altered psychological well-being, mental health and sleep: an online cross-sectional study
    Allen, Sarah F.
    Stevenson, Jodie
    Lazuras, Lambros
    Akram, Umair
    [J]. PSYCHOLOGY HEALTH & MEDICINE, 2022, 27 (02) : 343 - 351
  • [3] Serum cortisol concentration and COVID-19 severity: a systematic review and meta-analysis
    Amiri-Dashatan, Nasrin
    Koushki, Mehdi
    Parsamanesh, Negin
    Chiti, Hossein
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (03) : 766 - 772
  • [4] [Anonymous], Our Ongoing List of How Countries Are Reopening, and Which Ones Remain under Lockdown|Business Insider
  • [5] [Anonymous], 2023, Coronavirus Disease (COVID-19)
  • [6] [Anonymous], 2021, Financial Times
  • [7] [Anonymous], Cumulative Graph of COVID-19 Cases in Israel-Logarithmic Scale
  • [8] Low-Fluence Photodynamic Therapy versus Ranibizumab for Chronic Central Serous Chorioretinopathy
    Bae, So Hyun
    Heo, Jangwon
    Kim, Cinoo
    Kim, Tae Wan
    Shin, Joo Young
    Lee, Joo Yong
    Song, Su Jeong
    Park, Tae Kwann
    Moon, Sang Woong
    Chung, Hum
    [J]. OPHTHALMOLOGY, 2014, 121 (02) : 558 - 565
  • [9] In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy
    Bazzazi, Nooshin
    Ahmadpanah, Mohammad
    Akbarzadeh, Siamak
    Rabiei, Mohammad Ali Seif
    Holsboer-Trachsler, Edith
    Brand, Serge
    [J]. Neuropsychiatric Disease and Treatment, 2015, 11 : 1131 - 1136
  • [10] COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
    Bikdeli, Behnood
    Madhavan, Mahesh V.
    Jimenez, David
    Chuich, Taylor
    Dreyfus, Isaac
    Driggin, Elissa
    Der Nigoghossian, Caroline
    Ageno, Walter
    Madjid, Mohammad
    Guo, Yutao
    Tang, Liang V.
    Hu, Yu
    Giri, Jay
    Cushman, Mary
    Quere, Isabelle
    Dimakakos, Evangelos P.
    Gibson, C. Michael
    Lippi, Giuseppe
    Favaloro, Emmanuel J.
    Fareed, Jawed
    Caprini, Joseph A.
    Tafur, Alfonso J.
    Burton, John R.
    Francese, Dominic P.
    Wang, Elizabeth Y.
    Falanga, Anna
    McLintock, Claire
    Hunt, Beverley J.
    Spyropoulos, Alex C.
    Barnes, Geoffrey D.
    Eikelboom, John W.
    Weinberg, Ido
    Schulman, Sam
    Carrier, Marc
    Piazza, Gregory
    Beckman, Joshua A.
    Steg, Gabriel
    Stone, Gregg W.
    Rosenkranz, Stephan
    Goldhaber, Samuel Z.
    Parikh, Sahil A.
    Monreal, Manuel
    Krumholz, Harlan M.
    Konstantinides, Stavros V.
    Weitz, Jeffrey I.
    Lip, Gregory Y. H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (23) : 2950 - 2973